Additional aberrations of the ETV6 and RUNX1 genes have no prognostic impact in 229 t(12;21)(p13;q22)-positive B-cell precursor acute lymphoblastic leukaemias treated according to the NOPHO-ALL-2000 protocol

Gisela Barbany, Mette K Andersen, Kirsti Autio, Georg Borgström, Lucia Cavalier Franco, Irina Golovleva, Sverre Heim, Kristina Heinonen, Randi Hovland, Bertil Johansson, Johann H Johannsson, Eigil Kjeldsen, Ann Nordgren, Lars Palmqvist, Erik Forestier, Nordic Society of Paediatric Haematology and Oncology

5 Citations (Scopus)
Original languageEnglish
JournalLeukemia Research
Volume36
Issue number7
Pages (from-to)936-8
Number of pages3
ISSN0145-2126
DOIs
Publication statusPublished - 2012

Keywords

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols
  • Child
  • Child, Preschool
  • Chromosome Aberrations
  • Chromosomes, Human, Pair 12
  • Chromosomes, Human, Pair 21
  • Clinical Trials as Topic
  • Cohort Studies
  • Core Binding Factor Alpha 2 Subunit
  • Denmark
  • Finland
  • Humans
  • Iceland
  • Infant
  • Mutation
  • Norway
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
  • Prognosis
  • Proto-Oncogene Proteins c-ets
  • Repressor Proteins
  • Sweden
  • Translocation, Genetic

Cite this